You know, getting strength training as part of a weekly routine, as part of a lifestyle habit is relatively palatable
In fact, there are no large-scale clinical trials on many of the peptides being promoted on social media
We understand the importance of addressing both the physiological and behavioral aspects of weight management
The very high demand combined with the very high prices and limited insurance coverage for these weight loss drugs drove the rise of the market for compounded GLP-1s, says Mike DiStefano, PhD, an assistant professor at the Center for Pharmaceutical Outcomes Research at the University of Colorado in Anschutz
Accurate disclosures at the underwriting stage may need to be validated at the claims stage, and claims assessors will require a deep understanding of the use of AOMs to ensure accurate interpretation of disclosures made as part of the insurance application
Yes, GLP-1 is a hormone that is being developed as an anti-obesity drug (this was published two years before Ozempic)